383 studies found for:    dialysis [CONDITION] OR dialysis [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
Conditions: Functionally Anuric;   Hemodialysis/Peritoneal Dialysis
Intervention: Other: Adjuvant Peritoneal Dialysis in the context of ongoing Hemodialysis
2 Unknown  Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments
Condition: Cardiovascular Disease
Intervention: Procedure: dialysis
3 Not yet recruiting Routine and Deferred Dialysis Initiation
Condition: Chronic Kidney Disease
Interventions: Other: Algorithm for deferred dialysis intervention;   Other: Algorithm for routine dialysis intervention
4 Recruiting The Effect of Intra-abdominal t-PA and and DNase on Peritonitis in Peritoneal Dialysis Patients
Conditions: Peritoneal Dialysis;   Peritoneal Dialysis, Continuous Ambulatory
Interventions: Drug: Tissue Plasminogen Activator (tPA);   Drug: recombinant deoxyribonuclease (DNase)
5 Not yet recruiting Virtual Ward for Home Dialysis
Conditions: End Stage Renal Disease;   Kidney Failure;   Home Dialysis
Interventions: Other: Telephone follow-up;   Other: Sympton Assessment
6 Recruiting Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis
Conditions: End-stage Renal Disease (ESRD);   Kidney Disease
Interventions: Other: DIANEAL;   Other: EXTRANEAL
7 Recruiting An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Conditions: Healthy Subjects;   Cytomegalovirus Infection;   Dialysis
Interventions: Drug: ASP0113;   Drug: Placebo
8 Unknown  Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Conditions: End-Stage Kidney Disease;   Peritoneal Dialysis
Intervention: Drug: N-acetylcysteine
9 Recruiting Peritoneal Dialysis Versus Haemodialysis
Condition: Hemodialysis
Interventions: Procedure: Peritoneal dialysis;   Procedure: Haemodialysis
10 Unknown  The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
Conditions: Peritoneal Dialysis;   Hemodialysis
Intervention:
11 Recruiting Evaluation of Efficacy and Safety of Roxadustat in the Treatment of Anemia in Stable Dialysis Subjects
Condition: CKD Anemia in Stable Dialysis Patients
Interventions: Drug: Epoetin Alfa;   Drug: FG-4592
12 Not yet recruiting Improving Outcomes in Peritoneal Dialysis
Conditions: Chronic Kidney Disease;   Peritoneal Dialysis Access
Intervention:
13 Unknown  Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients
Condition: End-Stage Renal Disease
Interventions: Drug: 6 L dialysate;   Drug: 8 L dialysate
14 Recruiting A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration
Condition: End Stage Renal Disease
Intervention: Other: Dialysis session of at least 4.25 hours
15 Unknown  Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis
Conditions: End Stage Renal Disease;   Peritoneal Dialysis
Intervention:
16 Recruiting The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease
Conditions: Refractory Heart Failure;   Chronic Kidney Disease
Intervention: Drug: Peritoneal dialysis (PD)
17 Not yet recruiting Drug Eluting Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas
Condition: Dialysis Access Dysfunction
Interventions: Drug: paclitaxel (Cardionovum Legflow drug eluting balloon);   Device: Balloon angioplasty (Bard Dorado)
18 Recruiting The Effects Nutrition Status and Body Composition On Peritoneal Dialysis Outcome
Conditions: Peritoneal Dialysis;   Wasting and Malnutrition
Intervention:
19 Unknown  Bioimpedance as a Tool for Fluid Management in Peritoneal Dialysis (PD) Patients
Conditions: Fluid Status;   Peritoneal Dialysis
Intervention:
20 Unknown  Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Condition: Peritoneal Dialysis
Intervention: Drug: alendronate (Fosamax)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years